Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 70, No. 3, 2006   

Free Abstract     Article (Fulltext)     Article (PDF 117 KB)     

Clinical Study

Peroxisome Proliferator-Activated Receptor-gamma Polymorphism, Body Mass and Prostate Cancer Risk: Evidence for Gene-Environment Interaction
Joseph M. Zmudaa, c, Francesmary Modugnoa, c, Joel L. Weissfelda, c, Jane A. Cauleya, Donald L. Trumpd, Susan P. Moffetta, Robert E. Ferrellb

Departments of
aEpidemiology and
bHuman Genetics, Graduate School of Public Health, University of Pittsburgh, and the
cUniversity of Pittsburgh Cancer Institute, Pittsburgh, Pa., and
dDepartment of Medicine, Roswell Park Cancer Institute, Buffalo, N.Y., USA

Address of Corresponding Author

Oncology 2006;70:185-189 (DOI: 10.1159/000093805)


 goto top of page Key Words

  • Genetics
  • Obesity
  • Polymorphism
  • PPAR-gamma
  • Prostate cancer

 goto top of page Abstract

Background: Peroxisome proliferator-activated receptor (PPAR)-gamma has been implicated in prostate cancer. In the present case-control study, we tested if a common Pro12Ala polymorphism in PPAR-gamma is associated with the risk of prostate cancer. Methods: Ninety-one adult Caucasians with prostate cancer were recruited between 1994 and 1998. Blood samples were also obtained from 237 community-based Caucasian men without prostate cancer. Results: Twenty-six percent of cases and 19% of controls carried at least one Ala allele (p = 0.16). There was a significant interaction between the PPAR-gamma polymorphism and body mass index (BMI) in age-adjusted analyses (p < 0.05). Among the subgroup of men with BMI above 27.2 kg/m2 (median in controls), carriers of the Ala allele had over 2-fold greater risk of prostate cancer compared to those with the Pro12Pro genotype (odds ratio, OR: 2.77; 95% confidence interval, CI: 1.25-6.16). No association was observed between the PPAR-gamma genotype and prostate cancer among men with BMI below the median (OR: 0.68; 95% CI: 0.23-1.97). Conclusions: Our results suggest a novel gene-environment interaction between the PPAR-gamma Pro12Ala polymorphism and body mass in prostate cancer. Further research, particularly prospective studies, is needed to confirm these findings and to clarify the underlying mechanisms involved.

Copyright © 2006 S. Karger AG, Basel


 goto top of page Author Contacts

Assist. Prof. Joseph M. Zmuda
Department of Epidemiology, Graduate School of Public Health
University of Pittsburgh, 130 DeSoto Street
Pittsburgh, PA 15261 (USA)
Tel. +1 412 624 2970, Fax +1 412 624 7397, E-Mail zmudaj@edc.pitt.edu


 goto top of page Article Information

Supported in part by United States Public Health Service grants AR-35582, DK-46204, 1P60 AR44811, R25-CA57703-06A1, and K07-CA80668.

Received: April 1, 2005
Accepted after revision: February 25, 2006
Published online: June 7, 2006
Number of Print Pages : 5
Number of Figures : 0, Number of Tables : 3, Number of References : 27

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 16763406)
Download Citation
Cited In

This journal is part of the fourth subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues

Case Reports in Oncology


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.





copyright  © 2009 S. Karger AG, Basel